T lymphocyte response to Neisseria gonorrhoeae porin in individuals with mucosal gonococcal infections

Journal of Infectious Diseases

Volumn 180, Issue 3, 1999, Pages 762-773

  Simpson, Scott D ^a,b   Ho, Yu ^a   Rice, Peter A ^a   Wetzler, Lee M ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Resolution Pharmaceuticals Inc   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN G; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 2; INTERLEUKIN 4; ISOPROTEIN; PORIN; TUMOR NECROSIS FACTOR ALPHA; VERY LATE ACTIVATION ANTIGEN;

ANTIGEN EXPRESSION; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; GONORRHEA; HUMAN; HUMAN CELL; IMMUNOGLOBULIN PRODUCTION; IMMUNOSTIMULATION; LEUKOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; LYMPHOCYTIC INFILTRATION; MALE; MONONUCLEAR CELL; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION;

ADULT; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; FEMALE; GONORRHEA; HUMANS; IMMUNITY, MUCOSAL; IMMUNOGLOBULIN G; INTEGRINS; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-12; INTERLEUKIN-2; LYMPHOCYTE ACTIVATION; MALE; NEISSERIA GONORRHOEAE; PORINS; T-LYMPHOCYTES; T-LYMPHOCYTES, HELPER-INDUCER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032849397     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/314969     Document Type: Article

References (79)

1. 1. Soper DE. Pelvic inflammatory disease. Infect Dis Clin North Am 1994;8: 821-40.
2. 2. Hook EW Jr, Handsfield HH. Gonococcal infections in the adult. In: Holmes KK, Mardh PA, Sparling PF, et al., eds. Sexually transmitted diseases, 2d ed. New York: McGraw-Hill, 1990:149-60.
3. 3. Blake MS, Gotschlich EC. Functional and immunological properties of pathogenic neisserial surface proteins. In: Inouye M, ed. Bacterial outer membranes as model systems. New York: John Wiley, 1986:377-400.
4. 4. Douglas JT, Lee MD, Nikaido H. Protein I of Neisseria gonorrhoeae outer membrane is a porin. FEMS Microbiol Lett 1981;12:305-9.
5. 5. Cannon JG, Buchanan TM, Sparling PF. Confirmation of association of protein I serotype of Neisseria gonorrhoeae with ability to cause disseminated infection. Infect Immun 1983;40:816-9.
6. 6. Sparling PF. Biology of Neisseria gonorrhoeae. In: Holmes KK, Mardh PA, Sparling PF, et al., eds. Sexually transmitted diseases, 2d ed. New York: McGraw-Hill, 1990:131-48.
7. 7. Smith NH, Maynard Smith J, Spratt BG. Sequence evolution of the porB gene of Neisseria gonorrhoeae and Neisseria meningitidis: evidence of positive Darwinian selection. Mol Biol Evol 1995;12:363-70.
8. 8. Knapp JS, Sandstrom EG, Holmes KK. Overview of epidemiological and clinical applications of auxotype/serovar classification of Neisseria gonorrhoeae. In: Schoolnik GK, ed. The pathogenic Neisseriae. Washington, DC: American Society for Microbiology, 1985:6-12.
9. 9. Barlow AK, Heckels JE, Clarke IN. The class 1 outer membrane protein of Neisseria meningitidis: gene sequence and structural and immunologic similarities to gonococcal porins. Mol Microbiol 1989;3:131-9.
10. 10. Ward MJ, Lambden PR, Heckels JE. Sequence analysis and relationships between meningococcal class 3 serotype proteins and other porins from pathogenic and non-pathogenic Neisseria species. FEMS Microbiol Lett 1992;73:283-9.
11. 11. Butcher S, Sarvas M, Runeberg-Nyman K. Class 3 porin of Neisseria meningitidis: cloning and structure of the gene. Gene 1991;105:125-8.
12. 12. Jeanteur D, Lakey JH, Pattus F. The bacterial porin superfamily: sequence alignment and structure prediction. Mol Microbiol 1991;5:2153-64.
13. 13. Brunham RC, Plummer F, Slaney L, Rand F, DeWitt W. Correlation of auxotype and protein I type with expression of disease due to Neisseria gonorrhoeae. J Infect Dis 1985;152:339-43.
14. 14. Donegan SP, Jani DB, Flaherty EE, Heeren TC, Rice PA. The male to female transmission of Neisseria gonorrhoeae is influenced by level of antibody to gonococcal reduction modifiable protein (Rmp) or protein III. In: Conde-Glez CJ, Morse SA, Rice PA, Sparling PF, Calderón E, eds. Pathobiology and immunobiology of Neisseriaceae. Cuernavaca, Morelos, Mexico: Instituto Nacional de Salud Pública, 1994:645-50.
15. 15. Plummer FA, Simonsen JN, Chubb H et al. Epidemiologic evidence for the development of serovar-specific immunity after gonococcal infection. J Clin Invest 1989;83:1472-6.
16. 16. Lammel CJ, Sweet RL, Rice PA, et al. Antibody-antigen specificity in the immune response to infection with Neisseria gonorrhoeae. J Infect Dis 1985;152:990-1001.
17. 17. Brooks GF, Lammel CJ. Humoral immune response to gonococcal infections. Clin Microbiol Rev 1989;2 (Suppl):S5-10.
18. 18. Plummer FA, Chubb H, Simonsen JN, et al. Antibody to Rmp (outer membrane protein 3) increases susceptibility to gonococcal infection. J Clin Invest 1993;91:339-43.
19. 19. McMillan A, McNeillage G, Young H. Antibodies to Neisseria gonorrhoeae: a study of the urethral exudates of 232 men. J Infect Dis 1979;140:89-95.
20. 20. Plummer FA, Chubb H, Simonsen JN, et al. Antibodies to opacity proteins (Opa) correlate with a reduced risk of gonococcal salpingitis. J Clin Invest 1994;93:1748-55.
21. 21. Rice PA, Vayo HE, Tam MR, Blake MS. Immunoglobin G antibodies directed against protein III block killing of serum resistant Neisseria gonorrhoeae by immune sera. J Exp Med 1986;164:1735-48.
22. 22. Hadfield SG, Glynn AA. Analysis of antibodies in local and disseminated Neisseria gonorrhoeae infections by means of gel electrophoresis derived ELISA. immunology 1982;47:283-8.
23. 23. Rice PA, Hook EW, Blake MS, et al. A possible influence of vaccine induced Por, LOS and Rmp antibodies on the outcome of intraurethral challenge with Neisseria gonorrhoeae. In: Maiden MC, Feavers IM, Evans JD, Yost SE, eds. Neisseriae 94: Proceedings of the 9th International Pathogenic Neisseria Conference, Winchester, UK, 26-30 September, 1994. Winchester, UK: Merieux, 1994:483-4.
24. 24. Reiser H, Stadecker MJ. Costimulatory B7 molecules in the pathogenesis of infectious and autoimmune diseases. N Engl J Med 1996;335:1369-77.
25. 25. Jenkins MK. The ups and downs of T cell costimulation. Immunity 1994;1: 443-6.
26. 26. Janeway CA Jr, Bottomly K. Signals and signs for lymphocyte responses. Cell 1994;76:275-85.
27. 27. Boussiotis VA, Freeman GJ, Gribben JG, Nadler LM. The role of B7-1/B7-2:CD28/CLTA-4 pathways in the prevention of anergy, induction of productive immunity and down-regulation of the immune response. Immunol Rev 1996;153:5-26.
28. 28. Blake MS, Gotschlich EC. Purification and partial characterization of the major outer membrane protein of Neisseria gonorrhoeae. Infect Immun 1982;36:277-83.
29. 29. Blake MS, Gotschlich EC. Purification and partial characterization of the opacity-associated proteins of Neisseria gonorrhoeae. J Exp Med 1984; 159:452-62.
30. 30. Wetzler LM, Blake MS, Gotschlich EC. Characterization and specificity of antibodies to protein I of Neisseria gonorrhoeae produced by injection with various protein I adjuvant preparations. J Exp Med 1988;168: 1883-97.
31. 31. Wetzler LM, Gotschlich EC, Blake MS, Koomey JM. The construction and characterization of Neisseria gonorrhoeae lacking protein III in its outer membrane. J Exp Med 1989;169:2199-2209.
32. 32. Wetzler LM, Blake MS, Gotschlich EC. Gonococcal porin vaccine. In: Achtman M, Kohl P, Marchal C, Morelli G, Seiler A, Thiesen B, eds. Neisseriae 1990: Proceedings of the 7th International Pathogenic Neisseria Conference, Berlin, Germany, 9-14 September 1990. Berlin: Walter de Gruyter, 1991:313-20.
33. 33. Tsai CM, Frasch CE. A sensitive silver stain for detecting lipopolysaccharides in polyacrylamide gels. Analyt Biochem 1982;119:115-9.
34. 34. Tauschek M, Hamilton CW, Hall LA, Chomvarin C, Fyfe JA, Davies JK. Transcriptional analysis of the groESL operon of Neisseria gonorrhoeae. Gene 1997;189 (1):107-12.
35. 35. Wetzler LM, Blake MS, Barry K, Gotschlich EC. Gonococcal porin vaccine evaluation: comparison of Por proteosomes, liposomes and blebs isolated from rmp deletion mutants. J Infect Dis 1992;166:551-5.
36. 36. Coligan JE, Kruisbeek AM, Margulies DH, Shevach EM, Strober W, eds. Immunologic studies in humans: current protocols in immunology. New York: John Wiley & Sons, 1994:7.0.1-7.27.8.
37. 37. Coligan JE, Kruisbeek AM, Margulies DH, Shevach EM, Strober W, eds. Immunofluorescence and cell sorting: current protocols in immunology. New York: John Wiley & Sons, 1994;5.0.1-5.8.8.
38. 38. Prussin C, Metcalfe DD. Detection of intracytoplasmic cytokine using flow cytometry and directly conjugated anti-cytokine antibodies. J Immunol Methods 1995;188 (1):117-28.
39. 39. Picker LJ, Singh MJ, Zdraveski Z, et al. Direct demonstration of cytokine synthesis heterogeneity among human memory/effector T cells by flow cytometry. Blood 1995;86(4):1408-19.
40. 40. Fenton WA, Weissman JS, Horwitz MA. Putting a lid on protein folding: structure and function of the co-chaperone, GroES. Chem Biol 1996;3(3): 157-61.
41. 41. Biswas GD, Sparling PF. Characterization of 1bpA, the structural gene for a lactoferrin receptor in Neisseria gonorrhoeae. Infect Immun 1995;63 (8): 2958-67.
42. 42. Wetzler LM, Ho Y, Reiser H. Neisserial porins induce B lymphocytes to express costimulatory B7-2 molecules and to proliferate. J Exp Med 1996;183(3):1151-9.
43. 43. Sparkes BG. Immunomodulating activity of meningococcal antigens. Can J Microbiol 1983;29:1611-8.
44. 44. Melancon J, Murgita RA, DeVoe IW. Activation of murine B lymphocytes by Neisseria meningitidis and isolated meningococcal surface antigens. Infect Immun 1983;42:471-9.
45. 45. Melancon-Kaplan J, Gronvik KO, Murgita RA. Selective impairment of B cell function by Neisseria meningitidis. Cell Immunol 1986;100:247-59.
46. 46. Howell AL, Edkins RD, Rier SE, et al. Human immunodeficiency virus type 1 infection of cells and tissues from the upper and lower human female reproductive tract. J Virol 1997;71(5):3498-3506.
47. 47. Butcher EC, Picker LJ. Lymphocyte homing and homeostasis. Science 1996;272 :60-6.
48. 48. Quiding-Jabrink M, Nordstrom I, Granstrom G, et al. Differential expression of tissue-specific adhesion molecules on human circulating antibody-forming cells after systemic, enteric, and nasal immunizations: a molecular basis for the compartmentalization of effector B cell responses. J Clin Invest 1997;99:1281-6.
49. 49. Williams MB, Butcher EC. Homing of naive and memory T lymphocyte subsets to Peyer's patches, lymph nodes, and spleen. J Immunol 1997; 159:1746-52.
50. 50. Quinn ML, Weyer SJ, Lewis LA, Dyer DW, Wagner PM. Insertional inactivation of the gene for the meningococcal lactoferrin binding protein. Microb Pathog 1994;17(4):227-37.
51. i by circulating CD4+ cells with memory for intestinal rotavirus. J Clin Invest 1997;100:1204-8.
52. 52. Levine WC, Pope V, Bhoomkar A, et al. Increase in endocervical CD4 lymphocytes among women with nonulcerative sexually transmitted diseases. J Infect Dis 1998;177:167-74.
53. 53. Damle NK, Linsley PS, Ledbetter JA. Direct helper T cell induced B cell differentiation involves interaction between T cell antigen CD28 and B cell activation antigen B7. Eur J Immunol 1991;21:1277-82.
54. 54. Gimmi CD, Freeman GJ, Gribben JG, et al. B-cell surface antigen B7 provides a costimulatory signal that induces T cells to proliferate and secrete interleukin 2. Proc Natl Acad Sci U S A 1991;88:6575-9.
55. 55. Wetzler LM, Blake MS, Gotschlich EC. Protein I (Por) of Neisseria gonorrhoeae as an immunogen: liposomes, proteosomes and the lack of blocking antibodies. In: Transactions of the American Association of Physicians, 102d ed. Baltimore: Waverly Press, 1989;78-90.
56. 56. Qi HL, Tai JY, Blake MS. Expression of large amounts of neisserial porin proteins in Escherichia coli and refolding of the proteins into native trimers. Infect Immun 1994;62:2432-9.
57. 57. Wiertz EJ, van Gaans-van den Brink JA, Schreuder GM, Termijtelen AA, Hoogerhout P, Poolman JT. T cell recognition of Neisseria meningitidis class 1 outer membrane proteins: identification of T cell epitopes with selected synthetic peptides and determination of HLA restriction elements. J Immunol 1991;147:2012-8.
58. 58. Wiertz EJ, van Gaans van den Brink JA, Gausepohl H, Prochnicka-Chalufour A, Hoogerhout P, Poolman JT. Identification of T cell epitopes occurring in a meningococcal class 1 outer membrane protein using overlapping peptides assembled with simultaneous multiple peptide synthesis. J Exp Med 1992;176:79-88.
59. 59. Delvig AA, Rosenqvist E, Oftung F, Robinson JH. T-cell epitope mapping the PorB protein of serogroup B Neisseria meningitidis in B10 congenic strains of mice. Clin Immunol Immunopathol 1997;85:134-42.
60. 60. Guler ML, Gorham JD, Hsieh CS, et al. Genetic susceptibility to Leishmania: IL-12 responsiveness in TH1 cell development. Science 1996;271:984-7.
61. 61. Nabors GS, Farrell JP. Depletion of interleukin-4 in BALB/c mice with established Leishmania major infections increases the efficacy of antimony therapy and promotes Th1-like responses. Infect Immun 1994;62 (12): 5498-5504.
62. 62. Maggi E, Manetti R, Annunziato F, et al. Functional characterization and modulation of cytokine production by CD8+ T cells from human immunodeficiency virus infected individuals. Blood 1997;89:3672-81.
63. + T lymphocytes producing Th2-type cytokines (Tc2) in HIV-infected individuals. J Biol Regul Homeost Agents 1995;9:78-81.
64. 64. Mosmann TR, Li L, Sad S. Functions of CD8 T-cell subsets secreting different cytokine patterns. Semin Immunol 1997;9:87-92.
65. + cells in patients with atopic dermatitis. J Allergy Clin Immunol 1997;99:673-82.
66. + T cells secreting Th1 or Th2 cytokines. Immunity 1995;2:271-9.
67. + TC1 cells: loss of IL-2 synthesis and autonomous proliferation but retention of cytotoxicity and synthesis of other cytokines. J Exp Med 1995;182:1505-15.
68. 68. McHugh S, Deighton J, Rifkin I, Ewan P. Kinetics and functional implications of Th1 and Th2 cytokine production following activation of peripheral blood mononuclear cells in primary culture. Eur J Immunol 1996;26:1260-5.
69. 69. Paul WE, Seder RA. Lymphocyte responses and cytokines. Cell 1994;76: 241-51.
70. 70. Briskin M, Winsor-Hines D, Shyjan A, et al. Human mucosal addressin cell adhesion molecule-1 is preferentially expressed in intestinal tract and associated lymphoid tissue. Am J Pathol 1997;151:97-110.
71. 71. Kantele A, Kantele JM, Savilahti E, et al. Homing potentials of circulating lymphocytes in humans depend on the site of activation: oral, but not parenteral, typhoid vaccination induces circulating antibody-secreting cells that all bear homing receptors directing them to the gut. J Immunol 1997;158:574-9.
72. 72. Thapar MA, Parr EL, Parr MB. Secretory immune responses in mouse vaginal fluid after pelvic, parenteral, or vaginal immunization. Immunology 1990;70:121-5.
73. 73. Edwards JNT, Morris HB. Langerhan's cells and lymphocytes subsets in the female reproductive tract. Br J Obstet Gynaecol 1985;92:974-82.
74. 74. Rosenthal KL, Gallichan WS. Challenges for vaccination against sexually-transmitted diseases: induction and long-term maintenance of mucosal immune responses in the female genital tract. Semin Immunol 1997;9: 303-14.
75. 75. Parr MB, Kepple L, Parr EL. Antigen recognition in the female reproductive tract: II Endocytosis of horseradish peroxidase by Langerhans cells in murine vaginal epithelium. Biol Reprod 1991;45:261-5.
76. 76. Steinman RM. The dendritic cell system and its role in immunogenicity. Annu Rev Immunol 1991;9:271-309.
77. 77. Macatonia SE, Knight SC, Edwards AJ, Griffiths S, Fryer, P. Localization of antigen on lymph node dendritic cells after exposure to the contact sensitizer fluorescien isothiocyanate. Functional and morphological studies. J Exp Med 1987;166:1654-62.
78. 78. Austyn JM. Antigen uptake and presentation by dendritic lymphocytes. Semin Immunol 1992;4:227-36.
79. 79. Yeaman GR, Guyre PM, Fanger MW, et al. Unique CD8+ T cell-rich lymphoid aggregates in human uterine endometrium. J Leukoc Biol 1997;61: 427-35.